Envestnet Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
54,258
-2,433
| -4% | -$70K | ﹤0.01% | 2995 |
|
|
2025
Q1 | $1.9M | Sell |
56,691
-6,386
| -10% | -$214K | ﹤0.01% | 2770 |
|
|
2024
Q4 | $3.23M | Buy |
63,077
+8,751
| +16% | +$447K | ﹤0.01% | 2383 |
|
|
2024
Q3 | $2.78M | Buy |
54,326
+2,535
| +5% | +$130K | ﹤0.01% | 2461 |
|
|
2024
Q2 | $2.32M | Buy |
51,791
+9,859
| +24% | +$442K | ﹤0.01% | 2503 |
|
|
2024
Q1 | $1.96M | Buy |
+41,932
| New | +$1.96M | ﹤0.01% | 2580 |
|